Welcome to our dedicated page for Nakamoto SEC filings (Ticker: NAKA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Kindly MD, Inc. (NAKA) SEC filings page provides access to the company’s official regulatory disclosures as a publicly traded issuer. KindlyMD, a patient-first and healthcare data company with integrated healthcare services and a Bitcoin treasury strategy via its subsidiary Nakamoto Holdings Inc., uses filings with the U.S. Securities and Exchange Commission to report material events, corporate actions, and financial information.
Among the key documents available are Current Reports on Form 8-K, which the company uses to disclose significant developments. Recent 8-K filings have addressed topics such as the completion of the merger with Nakamoto, entry into and termination of material loan agreements secured by Bitcoin or other digital assets, authorization of a share repurchase program, receipt of a Nasdaq minimum bid price notice, and the establishment of dates and record dates for annual shareholder meetings. These filings also cover matters like redemption of a secured convertible debenture and the company’s financing arrangements with lenders focused on digital assets.
Investors can also review proxy materials, including the Definitive Proxy Statement on Schedule 14A, which outlines proposals submitted to stockholders, such as the election of directors, approval of converting Kindly MD from a Utah corporation to a Delaware corporation, ratification of the independent registered public accounting firm, and potential adjournment of the annual meeting. Notifications of late filing on Form 12b-25 (NT 10-Q) provide context when additional time is needed to complete quarterly reports, including explanations related to the accounting complexity of the merger with Nakamoto.
On Stock Titan, these filings are complemented by AI-powered tools that help summarize lengthy documents and highlight key points, such as new financing obligations, changes in capital structure, or updates on the company’s Bitcoin treasury strategy. Users can quickly locate information about quarterly and annual reporting, material agreements, shareholder votes, and listing status, as well as track how KindlyMD’s integrated healthcare operations and Bitcoin-focused activities are reflected in its regulatory record.
Nakamoto Inc. is offering up to $4,993,570,615.16 of Common Stock under an at-the-market sales agreement with multiple agents, registering the remaining capacity under an existing ATM program after prior sales of $6,429,384.84. Sales may be made from time to time through designated agents at market prices or negotiated transactions, with agent commissions up to 2.0% and customary indemnities. The prospectus describes intended uses of net proceeds for general corporate purposes, including pursuit of the company’s Bitcoin Treasury Strategy, and discloses recent M&A, financings and corporate changes including the August 2025 reverse merger, PIPE and debt financings, the February 2026 acquisitions of BTC Inc. and UTXO, and bitcoin holdings of approximately 5,342 BTC valued at $467.5 million as of December 31, 2025.
Nakamoto Inc. (NAKA) registers up to 413,354,801 shares of Common Stock for resale, comprised of up to 351,649,826 resale shares, 61,704,975 pre-funded warrant shares and limited issuances tied to IPO warrants and other previously issued securities. The Company is not selling any shares under this shelf; selling stockholders will sell the registered resale shares and the Company will receive proceeds only from any cash exercise of the registered warrants.
The prospectus states the Company may receive up to $3,725,217.66 from cash exercise of the Registered Warrants and that IPO Warrant exercise depends on the market trading price versus the $6.33 exercise price. The filing warns that substantial resale availability and ATM or other issuances could pressure the market price.
Nakamoto Inc. terminates the effectiveness of two Form S-3 shelf registration statements by filing Post-Effective Amendment Nos. 2 and 3 to those Registration Statements.
The terminated registrations had authorized up to $6,993,570,615.16 of securities (including $4,993,570,615.16 available under an at-the-market sales agreement) and a selling-stockholder registration for 438,607,381 shares plus 61,704,975 pre-funded-warrant shares. The company filed new S-3 shelf statements declared effective concurrently.
Nakamoto Inc. filed Post-Effective Amendments to terminate and deregister previously effective Form S-3 shelf registration statements and to remove any unsold securities from registration as of the effectiveness of these amendments. The terminated registrations had previously covered up to $6,993,570,615.16 of securities and an at-the-market component of $4,993,570,615.16 of common stock; a separate shelf registered resale by selling stockholders covered 438,607,381 shares and 61,704,975 pre-funded-warrant shares. The company filed new Form S-3 shelf statements declared effective concurrently to re-register the unsold securities.
Nakamoto Inc. filed Amendment No. 1 to a shelf registration registering up to $6,993,570,615.16 of securities, including an at-the-market program component of $4,993,570,615.16. The amendment updates disclosure items and files auditor consents, and it replaces a prior ASR registration that became unusable after the Company’s 2025 Form 10-K.
The prospectus describes a shelf for common stock, preferred stock, debt securities, warrants, rights, purchase contracts and units. Recent material actions disclosed include the August 2025 reverse merger and PIPE financing, repayment of a $200.0 million convertible debenture, the February 2026 acquisitions of BTC Inc. and UTXO, and Bitcoin holdings of 5,342 BTC valued at $467.5 million as of December 31, 2025.
Nakamoto Inc. filed an amendment to a shelf registration to combine prior resale registrations and update its preliminary prospectus. The filing registers resale by selling stockholders of up to 413,354,801 shares of Common Stock and registers the issuance by the Company of Common Stock issuable upon exercise of registered warrants.
The prospectus discloses 61,704,975 Pre-Funded Warrant Shares, PIPE Shares of 264,444,723, IPO Warrant exercise prices of $6.33 (tradable) and a Pre-Funded Warrant exercise price of $0.001. The company held approximately 5,342 Bitcoin valued at $467.5 million as of December 31, 2025, and reported roughly 690,018,254 shares outstanding as of April 6, 2026.
Nakamoto Inc. is asking stockholders at a May 8, 2026 virtual special meeting to approve a reverse stock split of its common stock at a ratio between 1‑for‑20 and 1‑for‑50, with the exact ratio set later by the board. The main goal is to raise the per‑share trading price above Nasdaq’s $1.00 minimum bid requirement; the stock most recently closed at $0.24 per share. A second proposal would allow adjournment of the meeting to solicit more votes if needed. The reverse split would reduce the 690,018,254 shares outstanding but leave the 10,000,000,000 authorized shares unchanged, increasing the number of shares available for future issuance and potential dilution.
Nakamoto Inc. has filed a shelf registration to offer up to $6,993,570,615.16 of securities, which includes an at-the-market (ATM) component of $4,993,570,615.16 and an ATM program with agents enabling up to $5.0 billion of common stock sales. The prospectus covers common stock, preferred stock, debt securities, warrants, rights, purchase contracts and units.
The company discloses recent corporate activity: it held approximately 5,342 Bitcoin valued at $467.5 million as of December 31, 2025; repaid in full a secured convertible debenture on September 30, 2025; completed mergers with BTC Inc. and UTXO in February 2026; and reported 690,018,254 shares of common stock issued and outstanding as of April 6, 2026. The prospectus is a shelf base prospectus; specific terms for any offering will be set in prospectus supplements.